Announcement

Mark Tullis

Mark is Co-founder/Editor of TechBuzz News. From Ogden, UT, Mark attended WSU, BYU, and Tufts. He has been involved in tech, media, publishing since the 80s.

Location Lehi, UT
Number of Articles 2518
Socials
Mark Tullis's Work 2518 Articles
Dec 16, 2021 Buzzworthy - December 17, 2021
Buzzworthy - December 17, 2021

Arena to be Acquired by Pfizer for $6.7 Billion On December 13, 2021 Pfizer Inc. and Arena Pharmaceuticals, Inc. announced an agreement whereby Pfizer will acquire Arena for $6.7 billion. The boards of directors of both companies have unanimously approved the merger. Pfizer will acquire all outstanding shares

by Mark Tullis
Money   -   Dec 15, 2021 Lumio Raises $110 Million from White Oak and Fiera Comox
Lumio Raises $110 Million from White Oak and Fiera Comox

On December 14, 2021, Lumio announced it has raised a $110 million investment led by White Oak with participation by Fiera Comox. White Oak is a San Francisco-based private equity firm (with offices in several cities) specializing in high-growth companies focused on environmental conservation and social responsibility. Founded

by Mark Tullis
Money   -   Dec 15, 2021 Lumio Raises $110 Million from White Oak and Fiera Comox
Lumio Raises $110 Million from White Oak and Fiera Comox

On December 14, 2021, Lumio announced it has raised a $110 million investment led by White Oak with participation by Fiera Comox. White Oak is a San Francisco-based private equity firm (with offices in several cities) specializing in high-growth companies focused on environmental conservation and social responsibility. Founded

by Mark Tullis
Dec 09, 2021 Buzzworthy - December 10, 2021
Buzzworthy - December 10, 2021

Recursion Announces Partnerships with Roche and Genentech On December 7, 2021, Recursion announced a collaboration with Roche and Genentech, a member of the Roche Group. Recursion is a Salt Lake City-based clinical-stage biotechnology company industrializing drug discovery, development through disruptive innovation. The company will work with both Roche

by Mark Tullis
Dec 09, 2021 Buzzworthy - December 10, 2021
Buzzworthy - December 10, 2021

Recursion Announces Partnerships with Roche and Genentech On December 7, 2021, Recursion announced a collaboration with Roche and Genentech, a member of the Roche Group. Recursion is a Salt Lake City-based clinical-stage biotechnology company industrializing drug discovery, development through disruptive innovation. The company will work with both Roche

by Mark Tullis
Money   -   Dec 07, 2021 Nomi Health Raises $110 Million in Series A Funding
Nomi Health Raises $110 Million in Series A Funding

On December 8, 2021, Orem-based Nomi Health announced the closing of a $110 million Series A funding round. This latest financing round was led by Rose Park Advisors, based in Boston and founded by the late celebrated author and Harvard Business School professor Clayton Christensen, and Arbor Ventures, a

by Mark Tullis
Money   -   Dec 07, 2021 Nomi Health Raises $110 Million in Series A Funding
Nomi Health Raises $110 Million in Series A Funding

On December 8, 2021, Orem-based Nomi Health announced the closing of a $110 million Series A funding round. This latest financing round was led by Rose Park Advisors, based in Boston and founded by the late celebrated author and Harvard Business School professor Clayton Christensen, and Arbor Ventures, a

by Mark Tullis
Dec 02, 2021 Buzzworthy - December 3, 2021
Buzzworthy - December 3, 2021

Tribe Wins $3,000 Grand Prize at the 2021-22 University of Utah Opportunity Quest On December 3, 2021, Tribe, a mobile platform for team-based addiction recovery and self-improvement, won first place and the $3,000 grand prize at the 2021-22 University of Utah Opportunity Quest business

by Mark Tullis
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Your link has expired. Please request a new one.
Great! You've successfully signed up.
Great! You've successfully signed up.
Welcome back! You've successfully signed in.
Success! You now have access to additional content.